# Antiretroviral Drug Interaction Study in Volunteers With HIV

> **NCT01479361** · PHASE1 · COMPLETED · sponsor: **National Institutes of Health Clinical Center (CC)** · enrollment: 36 (actual)

## Conditions studied

- HIV
- PCP
- Toxoplasmosis

## Interventions

- **DRUG:** Atovaquone 750 mg twice daily
- **DRUG:** Atovaquone 1500 mg twice daily

## Key facts

- **NCT ID:** NCT01479361
- **Lead sponsor:** National Institutes of Health Clinical Center (CC)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10-31
- **Primary completion:** 2014-02-20
- **Final completion:** 2014-02-20
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2018-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01479361

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01479361, "Antiretroviral Drug Interaction Study in Volunteers With HIV". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01479361. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*